Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) (FLACU) has a ROE of 18.67%, above the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow18.67%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s return on equity stands at 18.67%. That is above the sector sector average of -5.68%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) sits higher the its sector benchmark (-5.68%) with a ROE of 18.67%. That is roughly 428.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 18.67% for Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s ROE evolved across reporting periods, while the comparison chart places FLACU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.